IS4922A - Fjölpeptíð sem geta myndað formgerðir mótefnisvakabindinga með sérvirkni fyrir resus D mótefnisvaka, DNA-ið sem táknar þau og aðferðin til að búa þautil og notkun - Google Patents

Fjölpeptíð sem geta myndað formgerðir mótefnisvakabindinga með sérvirkni fyrir resus D mótefnisvaka, DNA-ið sem táknar þau og aðferðin til að búa þautil og notkun

Info

Publication number: IS4922A
Authority: IS; Iceland
Prior art keywords: antigen; dna; resus; specificity; saline
Prior art date: 1996-06-24

Application number

IS4922A

Other languages

English (en)

Other versions

IS2220B (is

Inventor

Miescher Sylvia

Vogel Monique

Stadler Beda

Morell Andreas

Imboden Martin

Amstutz Hanspeter

Original Assignee

Zlb Behring Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-24

Filing date

1998-12-11

Publication date

1998-12-11

1998-12-11 Application filed by Zlb Behring Ag filed Critical Zlb Behring Ag

1998-12-11 Publication of IS4922A publication Critical patent/IS4922A/is

2007-03-15 Publication of IS2220B publication Critical patent/IS2220B/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Mycology (AREA)
Cell Biology (AREA)
Pathology (AREA)
Epidemiology (AREA)
General Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)

IS4922A 1996-06-24 1998-12-11 Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra. IS2220B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96810421		1996-06-24
PCT/EP1997/003253 WO1997049809A1 (en)	1996-06-24	1997-06-20	Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use

Publications (2)

Publication Number	Publication Date
IS4922A true IS4922A (is)	1998-12-11
IS2220B IS2220B (is)	2007-03-15

Family

ID=8225636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4922A IS2220B (is)	1996-06-24	1998-12-11	Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra.

Country Status (23)

Country	Link
US (3)	US7038020B1 (is)
EP (1)	EP0920509B1 (is)
JP (1)	JP3841360B2 (is)
KR (1)	KR100361449B1 (is)
AT (1)	ATE272116T1 (is)
AU (1)	AU722127B2 (is)
BG (1)	BG64534B1 (is)
BR (1)	BR9709958A (is)
CA (1)	CA2258494C (is)
CZ (1)	CZ296807B6 (is)
DE (1)	DE69730031T2 (is)
DK (1)	DK0920509T3 (is)
ES (1)	ES2224255T3 (is)
HU (1)	HUP9902605A3 (is)
IL (1)	IL127595A (is)
IS (1)	IS2220B (is)
NO (1)	NO327947B1 (is)
NZ (1)	NZ333329A (is)
PL (1)	PL186019B1 (is)
RU (1)	RU2204602C2 (is)
SK (1)	SK284879B6 (is)
TR (1)	TR199802692T2 (is)
WO (1)	WO1997049809A1 (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1631000A (en) *	1998-11-19	2000-06-05	Incyte Pharmaceuticals, Inc.	Immunoglobulin superfamily proteins
EP1106625A1 (en) *	1999-11-17	2001-06-13	ZLB Bioplasma AG	Rhesus D specific peptide sequences
FR2807767B1 (fr)	2000-04-12	2005-01-14	Lab Francais Du Fractionnement	Anticorps monoclonaux anti-d
US8288322B2 (en)	2000-04-17	2012-10-16	Dyax Corp.	Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
CA2798625C (en)	2000-04-17	2017-01-24	Dyax Corp.	Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins
US20030049731A1 (en) *	2000-12-05	2003-03-13	Bowdish Katherine S.	Engineered plasmids and their use for in situ production of genes
WO2002061071A2 (en)	2000-12-18	2002-08-08	Dyax Corp.	Focused libraries of genetic packages
AU2016225923B2 (en) *	2001-04-17	2018-07-05	Takeda Pharmaceutical Company Limited	Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries
RU2209434C1 (ru) *	2001-11-15	2003-07-27	Российский центр судебно-медицинской экспертизы Министерства здравоохранения Российской Федерации	Способ получения резус-пептидов анти-d, специфически выявляющих антиген rhd в следах крови и выделений
US20040067532A1 (en)	2002-08-12	2004-04-08	Genetastix Corporation	High throughput generation and affinity maturation of humanized antibody
US8288109B2 (en)	2004-07-20	2012-10-16	Symphogen A/S	Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
EA014182B1 (ru) *	2004-07-20	2010-10-29	Симфоген А/С	КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
GB0706558D0 (en) *	2007-04-03	2007-05-09	Common Services Agency For The	Diagnostic assay
EP3124497B1 (en)	2007-09-14	2020-04-15	Adimab, LLC	Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en)	2007-09-14	2014-11-04	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
US12529164B2 (en)	2007-09-14	2026-01-20	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
US20090093004A1 (en)	2007-10-04	2009-04-09	Symphogen A/S	Potency assay
WO2009114815A1 (en)	2008-03-13	2009-09-17	Dyax Corp	Libraries of genetic packages comprising novel hc cdr3 designs
JP5780951B2 (ja)	2008-04-24	2015-09-16	ダイアックスコーポレーション	新規のｈｃｃｄｒ１、ｃｄｒ２、およびｃｄｒ３設計、ならびに新規のｌｃｃｄｒ１、ｃｄｒ２、およびｃｄｒ３設計を含む、遺伝子パッケージのライブラリ
KR102318383B1 (ko)	2010-07-16	2021-10-27	아디맵 엘엘씨	항체 라이브러리
BR112015010240A2 (pt) *	2012-11-06	2017-08-22	Medimmune Ltd	Terapias de combinação através do uso de mo-léculas de ligação de psl e de pcrv anti-pseudomonas
JP7278270B2 (ja) *	2017-10-20	2023-05-19	シーエスエル、リミテッド	方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2127434A (en)	1982-09-17	1984-04-11	Univ London	A human monoclonal antibody against Rhesus D antigen
GB8722018D0 (en) *	1987-09-18	1987-10-28	Central Blood Lab Authority	Human anti-rh(d)monoclonal antibodies
GB8925590D0 (en) *	1989-11-13	1990-01-04	Central Blood Lab Authority	Monoclonal antibodies

1997
- 1997-06-20 AU AU33423/97A patent/AU722127B2/en not_active Expired
- 1997-06-20 KR KR10-1998-0710975A patent/KR100361449B1/ko not_active Expired - Fee Related
- 1997-06-20 DE DE69730031T patent/DE69730031T2/de not_active Expired - Lifetime
- 1997-06-20 WO PCT/EP1997/003253 patent/WO1997049809A1/en not_active Ceased
- 1997-06-20 SK SK1761-98A patent/SK284879B6/sk not_active IP Right Cessation
- 1997-06-20 CZ CZ0395998A patent/CZ296807B6/cs not_active IP Right Cessation
- 1997-06-20 TR TR1998/02692T patent/TR199802692T2/xx unknown
- 1997-06-20 CA CA002258494A patent/CA2258494C/en not_active Expired - Fee Related
- 1997-06-20 RU RU99101121/13A patent/RU2204602C2/ru not_active IP Right Cessation
- 1997-06-20 NZ NZ333329A patent/NZ333329A/xx not_active IP Right Cessation
- 1997-06-20 EP EP97929244A patent/EP0920509B1/en not_active Expired - Lifetime
- 1997-06-20 IL IL12759597A patent/IL127595A/xx not_active IP Right Cessation
- 1997-06-20 AT AT97929244T patent/ATE272116T1/de active
- 1997-06-20 DK DK97929244T patent/DK0920509T3/da active
- 1997-06-20 BR BR9709958A patent/BR9709958A/pt not_active Application Discontinuation
- 1997-06-20 PL PL97330794A patent/PL186019B1/pl not_active IP Right Cessation
- 1997-06-20 JP JP50232398A patent/JP3841360B2/ja not_active Expired - Lifetime
- 1997-06-20 ES ES97929244T patent/ES2224255T3/es not_active Expired - Lifetime
- 1997-06-20 HU HU9902605A patent/HUP9902605A3/hu unknown
- 1997-06-20 US US09/147,443 patent/US7038020B1/en not_active Expired - Fee Related
1998
- 1998-12-11 IS IS4922A patent/IS2220B/is unknown
- 1998-12-15 BG BG103016A patent/BG64534B1/bg unknown
- 1998-12-23 NO NO19986088A patent/NO327947B1/no not_active IP Right Cessation
2005
- 2005-06-20 US US11/155,775 patent/US7399471B2/en not_active Expired - Fee Related
2006
- 2006-01-18 US US11/333,197 patent/US7429647B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IS2220B (is)	2007-03-15
ATE272116T1 (de)	2004-08-15
US7038020B1 (en)	2006-05-02
EP0920509B1 (en)	2004-07-28
BG64534B1 (bg)	2005-06-30
CA2258494A1 (en)	1997-12-31
PL330794A1 (en)	1999-06-07
HUP9902605A2 (hu)	1999-11-29
ES2224255T3 (es)	2005-03-01
US20050266013A1 (en)	2005-12-01
WO1997049809A1 (en)	1997-12-31
HUP9902605A3 (en)	2001-11-28
DE69730031D1 (de)	2004-09-02
KR20000022530A (ko)	2000-04-25
SK284879B6 (sk)	2006-01-05
DE69730031T2 (de)	2005-06-16
IL127595A (en)	2005-09-25
DK0920509T3 (da)	2004-12-06
TR199802692T2 (xx)	1999-03-22
EP0920509A1 (en)	1999-06-09
BG103016A (en)	1999-08-31
JP2000515732A (ja)	2000-11-28
AU3342397A (en)	1998-01-14
SK176198A3 (en)	1999-07-12
CZ296807B6 (cs)	2006-06-14
IL127595A0 (en)	1999-10-28
NO986088L (no)	1999-02-24
US20060165694A1 (en)	2006-07-27
PL186019B1 (pl)	2003-09-30
CA2258494C (en)	2008-05-27
JP3841360B2 (ja)	2006-11-01
US7429647B2 (en)	2008-09-30
AU722127B2 (en)	2000-07-20
NO327947B1 (no)	2009-10-26
NZ333329A (en)	2000-07-28
US7399471B2 (en)	2008-07-15
CZ395998A3 (cs)	1999-05-12
BR9709958A (pt)	1999-08-10
NO986088D0 (no)	1998-12-23
RU2204602C2 (ru)	2003-05-20
KR100361449B1 (ko)	2003-01-24

Publication	Publication Date	Title
IS4922A (is)	1998-12-11	Fjölpeptíð sem geta myndað formgerðir mótefnisvakabindinga með sérvirkni fyrir resus D mótefnisvaka, DNA-ið sem táknar þau og aðferðin til að búa þautil og notkun
ATE418340T1 (de)	2009-01-15	Zusammensetzungen und methoden zur identifikation von antigenen, die eine immunantwort hervorrufen
WO2001093913A3 (en)	2003-01-16	T cell receptor fusions and conjugates and methods of use thereof
TR199801722T2 (xx)	1998-12-21	Peptit imm�nojenler.
GR3036229T3 (en)	2001-10-31	Method for the production of antihuman antigen receptors and uses thereof
WO2002072636A3 (en)	2003-04-17	Crystals of whole antibodies and fragments thereof and methods for making and using them
NO934801L (no)	1994-02-21	CTL4A reseptor, fusjonsproteiner som inneholder den og anvendelse derav
EP0757099A3 (en)	1999-05-26	CTLA4 mutant molecules and uses thereof
WO2001085790A3 (en)	2002-07-18	Mammalian cytokine receptor subunit proteins, related reagents and methods
WO2004073319A3 (en)	2005-02-17	Methods and compounds for raising antibodies and for screening antibody repertoires
DK1167389T3 (da)	2007-11-12	Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
EP1433792A3 (en)	2004-11-17	Human receptor proteins, related reagents and methods
DK0969873T3 (da)	2006-10-09	Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf
WO2003003986A3 (en)	2004-07-01	Parathyroid hormone antibodies and related methods
TR200102877T2 (tr)	2002-01-21	İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
WO2001057219A3 (en)	2002-03-07	Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
DE69833455D1 (de)	2006-04-20	Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs)
NZ500151A (en)	2001-01-26	A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
WO2002051237A3 (en)	2004-02-26	Helicobacter proteins, nucleic acids and uses thereof
WO2002012535B1 (en)	2002-07-18	Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy
WO1999019480A3 (en)	1999-06-24	Human receptor proteins; related reagents and methods
WO2002085409A3 (en)	2002-12-27	Methods and compositions for inducing an immune response to an antigen
MX9709446A (es)	1998-07-31	Metodo para preparar un anticuerpo monoclonal, anticuerpo monoclonal, una composicion farmaceutica y un reactivo de diagnostico.